SCHEMBL1034039

SCHEMBL1034039

CCOC(=O)C(C)Oc1ccc(C(=O)CCc2sc3ccccc3c2C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CNR2 P34972 4/20 0.45
CNR1 P21554 1/20 0.44
ALDH1A1 P00352 5/20 0.40
MAPT P10636 4/20 0.40
KMT2A Q03164 5/20 0.40
NOD2 Q9HC29 1/20 0.40
KDM4E B2RXH2 2/20 0.39
PTPN1 P18031 2/20 0.39
MEN1 O00255 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TP53 P04637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
EPHX2 P34913 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031809 0.89 CNR2 (0.46) CNR2CNR1ALDH1A1MAPTPTPN1
SCHEMBL1034043 0.84 IDH1 (0.41) LMNAL3MBTL1ALDH1A1MAPTKMT2A
SCHEMBL1034265 0.84 IDH1 (0.43) LMNAL3MBTL1ALDH1A1MAPTKMT2A
SCHEMBL1035195 0.73 PPARA (0.40)
SCHEMBL1034038 0.73 ABCB1 (0.46) LMNAL3MBTL1CNR2ALDH1A1MAPT
SCHEMBL1035525 0.72 CYP1A2 (0.45) LMNAL3MBTL1CNR2CNR1ALDH1A1
SCHEMBL19253753 0.72 LMNA (0.49) LMNAL3MBTL1ALDH1A1MAPTKMT2A
SCHEMBL1034852 0.71 FBP1 (0.41) LMNACNR2ALDH1A1MAPTKMT2A
SCHEMBL11653779 0.70 KMT2A (0.56) LMNAL3MBTL1ALDH1A1MAPTKMT2A
SCHEMBL11201574 0.70 PARP10 (0.62) LMNAL3MBTL1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD LMNA 2368/4885L3MBTL1 2525/4885CNR2 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.